AHA 2021: EAST-AFNET 4: Early Rhythm Control was Consistent in AF Patterns | Prof Andreas Götte

Подробнее о видео

Watch the full video on Radcliffe Cardiology here:

In this short video interview, Prof Andreas Goette (St Vincenz Hospital Paderborn, Paderborn, DE) discusses the findings from the the EAST-AFNET 4 Trial. The trial investigated whether rhythm control therapy delivered within one year after AF diagnosis improves outcomes. The trial, presented at AHA 21, demonstrated that clinical benefit of early rhythm control was consistent in AF patterns.

Discussion Points:
-Unmet Needs in the Management of Patients with AF
-Trial Population and Design
-Key Results
-Implications for Practice and for Guidelines
-Next Steps

Recorded remotely from Paderborn, 2021.

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.